Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Citigroup Maintains Neutral on Navient, Raises Price Target to $19

Citigroup Maintains Neutral on Navient, Raises Price Target to $19

Citigroup analyst Arren Cyganovich maintains Navient (NASDAQ:NAVI) with a Neutral and raises the price target from $15 to $19.

byBenzinga Newsdesk

February 1, 2023

1 minute read

Citigroup analyst Arren Cyganovich maintains Navient (NASDAQ:NAVI) with a Neutral and raises the price target from $15 to $19.

Analyst Ratings

What 10 Analyst Ratings Have To Say About Cinemark Hldgs

By Benzinga Insights

September 19, 2:00 PM

Within the last quarter, Cinemark Hldgs (NYSE:CNK) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat…

CNK

News

Elsie Biotechnologies Announced Collaboration With GSK to Accelerate Oligonucleotide Discovery Technologies

By Charles Gross

July 10, 7:05 AM

Elsie Biotechnologies, Inc., a biopharmaceutical company unlocking the full potential of oligonucleotide therapeutics, announced today a research collaboration agreement with GSK plc (NYSE:GSK) to advance the discovery

GSK

HCA Healthcare Q3 EPS $3.93 Beats $3.88 Estimate, Sales $14.97B Miss $15.00B Estimate

By Benzinga Newsdesk

October 21, 6:34 AM

HCA Healthcare (NYSE:HCA) reported quarterly earnings of $3.93 per share which beat the analyst consensus estimate of $3.88 by 1.29 percent. This is a 14 percent decrease over earnings of $4.57 per share from the same

HCA